Screener
Aurinia Pharmaceuticals AUPH Interest Expense
Interest Expense at other companies
Segments
By geography
Other financials
Where this comes from
Reported directly by Aurinia Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:InterestExpenseNonoperating.
The source filing: Aurinia Pharmaceuticals’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 6, 2026, 8:16 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001600620-26-000062
FAQ
- What is Aurinia Pharmaceuticals's interest expense?
- Aurinia Pharmaceuticals (AUPH) reported interest expense of $948K in Q2 2026.
- How has Aurinia Pharmaceuticals's interest expense changed year-over-year?
- Aurinia Pharmaceuticals's interest expense decreased by 15.1% year-over-year, from $1.12M to $948K.
- What does interest expense mean?
- Cost of borrowing — interest paid or accrued on bonds, bank loans, credit facilities, finance leases, and other debt obligations.
Ask your AI about Aurinia Pharmaceuticals's interest expense.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude